|
|
|
Journal of Bacteriology, February 2004, p . 1078-1083, Vol . 186, No . 4
|
| ABSTRACT |
|---|
At the onset of endospore formation in Bacillus subtilis, the
DNA binding protein Spo0A activates transcription from two typesof
promoters . The first type includes the spoIIG and spoIIE
promoters, which are used by
A-RNA
polymerase, whereas the secondtype includes the spoIIA
promoter, which is used by RNA polymerasecontaining the secondary
sigma factor
H .
Previous genetic analyseshave identified specific amino acids in
-helix
E of Spo0A thatare important for activation of Spo0A-dependent,
A-dependent
promoters . However, these amino acids are not required for activation
of the
H-dependent
spoIIA promoter . We now report the effectsof additional
single-amino-acid substitutions and the effectsof deletions in
-helix
E . The effects of alanine substitutionsrevealed one new position
[239] in Spo0A that appears to bespecifically required for
activation of the
A-dependent
promoters.Based on the effects of a deletion mutation, we suggest
that
-helix
E in Spo0A is not directly involved in interaction with
H-RNA
polymerase.
| INTRODUCTION |
|---|
Initiation of endospore formation in Bacillus subtilis is controlled
by the DNA binding protein Spo0A, which activates transcription
from several promoters, including spoIIG [11],
spoIIE [17],and spoIIA [2,
15], by binding to sites near the -35 regionof
these promoters . The spoIIG and spoIIE promoters are used
by
A-RNA
polymerase, whereas the spoIIA promoter is used byRNA
polymerase containing the secondary sigma factor
H .
Previousstudies conducted by Buckner et al . [1]
and Hatt and Youngman[4] identified a
14-amino-acid region in the C terminus of Spo0A[from residues 227 to
240] important for activation of Spo0A-dependent,
A-dependent
promoters . Specifically single-amino-acid substitutionsat positions
G227, I229, S233, F236, and V240 result in reducedability to
stimulate transcription of
A-specific
promoters whilehaving no effect on stimulation of
H-dependent
promoters [1,4] . In addition to
these mutations that specifically impair
A-dependent
promoter activation, Buckner et al . [1] also report
that a mutant form of Spo0A [S231F] suppresses the sporulationdefect
of H359R and several other substitutions in
A,
againsuggesting that the region around residue 231 in Spo0A is
importantfor
A-dependent
promoter activation . Interestingly, all mutationsin Spo0A affecting
the ability of
A-dependent
RNA polymeraseto activate transcription cluster in
-helix
E, a flexible helixin the C terminus of the protein that is
positioned away fromthe core structure of the protein [7,
18] [Fig . 1] . Taken together
these results suggest that
-helix
E perhaps contacts
A-RNA
polymerasewhen bound to promoters to stimulate transcription.
|
It is not known whether all the amino acid residues in
-helix
E that are involved in stimulation of
A-directed
transcriptionhave been identified or whether any of the amino acids
in
-helix
E play a direct role in activation of
H-RNA
polymerase . Therefore,we examined the effects of additional
single-amino-acid substitutionsand the effects of deletions in
-helix
E on activation of
A-
and
H-dependent
promoters.
| MATERIALS AND METHODS |
|---|
Bacterial strains and culture media. Routine microbiological
manipulations and procedures were carriedout by standard techniques
as described by Harwood and Cutting[3] . The
concentrations of antibiotics used for selection onLuria broth or
Difco sporulation media [DSM] were 5 µg/mlfor choramphenicol, 100
µg/ml for spectinomycin, and 100µg/ml for ampicillin . Cultures were
in grown in Luriabroth, and sporulation was induced by nutrient
exhaustion inDSM . Competent cells were prepared and transformed by
the two-stepmethod as described by Harwood and Cutting [3].
The B . subtilis strains used [Table 1] are all derivatives ofJH642 and contain the trpC2 and phe-1 alleles . Plasmids derivedfrom pCB2 [1] were used for inserting various mutations at thewild-type spo0A locus.
|
In order to create the spo0A deletion strain [EUAKB78], the
5'-flanking DNA of spo0A was PCR amplified with primers 0AUS5FOR
[HindIII end] and 0ADS5REV [BclI end] and was cloned into
HindIII-BclI-digestedpCB3 [1] to
generate plasmid pAK53 . pAK53 was linearized withScaI and was
transformed into JH642 as previously describedby Buckner et al . [1] .
Chromosomal DNA was isolated from a spectinomycin[100
µg/ml]-resistant transformant by using the QiampDNA Mini Kit [Qiagen
Inc., Valencia, Calif.] and was subjectedto PCR to determine if the
gene replacement of spectinomycinfor spo0A occurred . The
following PCR primers were used in combination,0AUUS5FOR and SpecREV
or 0ADS2REVand SpecFOR, to confirm theallelic replacement of the
spo0A with the spectinomycin gene.
The QuikChange site-directed mutagenesis kit [Stratagene, La Jolla, Calif.] was used to create mutations in Spo0A that resultedin single alanine substitutions . Briefly, pCB2 was used to createsingle alanine substitutions from amino acid positions 234 to239 of Spo0A . The combination of FOR and REV primers listedin Table 2 was used to make the single-amino-acid substitutions,and the resulting plasmids for each mutation were subjectedto sequencing by using the 0AUS4FOR and 0A3CREV primers to ensurethe presence of the desired mutation.
|
Overlapping PCR was used to create three different deletionswithin
the coding sequence of Spo0A . In deletion 1, amino acidsfrom
positions 225 to 244 were deleted, and in deletion 2, aminoacids
from positions 233 to 241 were deleted, while in the thirdclass of
deletion amino acids from positions 229 to 241 weredeleted . In the
first round of PCR, the 5' end of the codingsequence [from the
starting methionine to either amino acidposition S225, S233, or
I229] was amplified with forward primer0AUSFOR in combinations with
reverse primer 0ADS3REV, 0ADS4REV,or 0ADS5REV . This generated three
PCR products that containedoverlapping complementary regions at
their 3' end to primers0AUS2FOR, 0AUS3FOR, and 0AUS4FOR primers,
respectively . In thesecond round, the 3' end of the Spo0A coding
sequence [fromamino acid positions A244 or S241 to S267] was
amplified withprimer 0AUS2FOR, 0AUS3FOR, or 0AUS4FOR in combination
with 0ADS6REV.In the third step, the products of the first- and
second-roundprimers were combined and reamplified with outer primers
0AUSFORand 0ADS6REV . This gave PCR products that now contained the
entire spo0A sequence with deletions incorporated within them.
The PCR products obtained from the third round were digested
with BclI and HindIII and were cloned into BamHI-HindIII-digested
pCB3, thus giving rise to three different integrational vectors
[pAK21, pAK22, and pAK23] . To confirm that the deletions werein
frame with the coding sequence, plasmids pAK21, pAK22, andpAK23 were
sequenced with primer 0A3CREV.
Each mutant derivative of pCB2 was linearized with ScaI and was transformed into competent JH642 . Chromosomal DNA was prepared from spectinomycin-resistant colonies and was subjected to PCRwith primer sets 0AUUSFOR and SpecFOR and 0ADSREV2 and SpecREVto indicate that recombination occurred at the correct locationon the chromosome . The resulting PCR fragment was then sequencedwith 0AUS4FOR and 0A3CREV to confirm the presence of the desiredmutation.
In order to measure the effects that Spo0A mutations had on
A-
and
H-RNAP
holoenzyme-transcribed promoters, each of themutant strains was
transduced with an SPß lysate containingeither an spoIIA-lacZ,
spoIIG-lacZ, or abrB-lacZ reporter, aspreviously
described by Henriques et al . [5] . All strains used
are listed in Table 1.
Sporulation assay. Sporulation was induced by medium exhaustion in DSM as describedpreviously [12] . Sporulation efficiency was determined in 30-hcultures as the total number of heat-resistant [80°C for20 min] CFU compared with the total number of CFU before heattreatment . Data presented were from representative experiments.Similar results were obtained in at least three independentexperiments.
ß-Galactosidase activity. Cultures were grown in duplicate in DSM with the appropriateantibiotics to initiate sporulation . Two 300-µl aliquotsof each culture were collected, i.e., one to measure the opticaldensity and the other to assay for ß-galactosidase activity . Enzymatic activity is reported in Miller units [5].
In vivo mutagenesis with EMS. The strain to be mutagenized was plated on DSM agar containingthe appropriate antibiotics and was incubated for 36 h at 37°C.A sterile piece of filter paper with 3 drops of ethyl methanesulfonate[EMS] [1.7 mg/ml; Sigma] was placed at the center of the plate.The cultures were further incubated for 24 h at 37°C, andthe plates were exposed to chloroform vapor for 15 min to killall nonsporulating cells . The plate contents were incubatedfor 48 h at 37°C to allow any spores to germinate . Colonies were seen only with the EMS-mutagenized strain EUAKB38 carrying the deletion 1 derivate of Spo0A . Single colonies [15] were picked from DSM plates and were streaked out to Luria broth plates . Chromosomal DNA was prepared from each of these coloniesand was used to transform EUAKB11 [wild type-Spo0A; spoIIA-lacZ]. The transformants were selected for spectinomycin resistance[the marker for the spo0A] and were scored for blueness . These transformations revealed that all the suppressor mutations were linked to the spo0A gene.
Chromosomal DNA was prepared from each of 15 strains, and the spo0A gene was amplified with primers 0AUS4FOR and 0A3CREV.The resulting PCR product was sequenced with primers to identifythe position of the new mutation . All sequencing was done atthe Emory Core DNA facility [Emory University, Atlanta, Ga.].
| RESULTS AND DISCUSSION |
|---|
Identification of a new position in
-helix
E of Spo0A that is required for
A-dependent
promoter activation. To determine whether additional amino acids in
-helix
E areinvolved in stimulation of
A-dependent
promoters and if anyof these amino acids play a role in stimulation
of
H-directed
transcription, we isolated mutants that produced single alanine
substitutions at each position from 234 to 239 in Spo0A . Toassay the
effects of the single alanine substitutions in Spo0Aon expression of
Spo0A-regulated promoters, we transduced thesemutants with
specialized SPß phage lysates that carriedeither fusions of
spoIIG-lacZ [an Spo0A-activated,
A-dependent
promoter], spoIIA-lacZ [an Spo0A-activated,
H-dependent
promoter],or abrB-lacZ [an Spo0A-repressed promoter] . We also
isolatedisogenic transductants of a strain containing a
spectinomycinmarker linked to the wild-type spo0A allele and
of a straincarrying a deletion of the spo0A locus . All of the
strains werecultured in DSM, and the accumulation of ß-galactosidase
was monitored during endospore formation . Three of the single
alanine substitutions [L235A, G237A, and Y238A] had little effecton
the expression of spoIIG-lacZ [Table 3] . These mutants
alsoformed heat-resistant spores at frequencies similar to that
of the wild-type strain [Table 3] . However, substitution
ofmutations F236A and T239A resulted in reduced expression of
spoIIG-lacZ and spore formation [Table 3; Fig.
2] . The T239Asubstitution caused increased
expression of spoIIA-lacZ andhad little to no effect on
expression of abrB-lacZ [Table 3;Fig.
2] . These latter results indicate that T239A replaced Spo0A
functions as least as well as wild-type Spo0A in activating
spoIIA transcription and in repressing abrB transcription . Therefore,
the T239A substitution probably does not grossly alter structure,
stability, or phosphorylation properties of the protein . Evidently,
the side chain of T239 is required specifically for activation
of the
A-dependent
spoIIG promoter.
|
|
Substitution of alanine for the phenylalanine at position 236[F236A]
of Spo0A also reduced the expression of spoIIG-lacZ[Table
3] . However, this substitution also reduced expression
of spoIIA-lacZ [Table 3] . This substitution did
not preventrepression of abrB-lacZ expression; therefore,
this form ofSpo0A probably accumulates and binds DNA like wild-type
Spo0A.Substitution of serine for phenylalanine at position 236 is
also reported to have similar
A-
and
H-dependent
effects inan independent screen conducted by Hatt and Youngman [4] .
However,since replacement of phenylalanine at position 236 with
eitherserine or an alanine reduced transcription from both the
A-dependent
and
H-dependent
promoters, it is not clear whether this substitutiondefines a
position in Spo0A that is directly involved in
A
or
H
promoter activation or whether the substitution has a subtle,
indirect effect on accumulation or phosphorylation of the protein.In
summary, the effects of the alanine substitutions revealedone new
position [T239] that appears to be specifically requiredfor
activation of a
A-dependent
promoter and another amino acid[F236] that affects both
A-
and
H-dependent
promoter activation.However, in the latter case we cannot eliminate
the possibilityof an indirect involvement of F236 in promoter
activation.
-Helix
E of Spo0A is not required for
H-dependent
promoter activation. Experimental results [1,
4] previously identified amino acidsubstitutions
in
-helix
E of Spo0A that specifically reducedactivation of
A-dependent
promoters; however, no substitutionshave been described in this
region that specifically affect
H-dependent
promoter activation . Therefore, it is not knownwhether
-helix
E is involved directly in
H-dependent
promoteractivation . To test the role of
-helix
E, we used oligonucleotide-directedmutagenesis to create alleles
encoding three different deletionswithin this helix [Fig.
3] . The deletion limits and the placementsof
linker glycine residues were designed to minimize the effectof
deletions on the remaining structure [Fig . 3] . We then tested
the effects of the deletions on expression of the Spo0A-regulated
promoter-lacZ fusions . All three deletions abolished transcription
from the spoIIA and spoIIG promoters [data not shown] .
However,the three deletion derivatives of Spo0A repressed expression
of abrB-lacZ [data not shown], suggesting that these deletion
derivatives of Spo0A retained their ability to bind DNA.
|
We expected that deletion of
-helix
E would prevent activationof
A-dependent
promoters, since several amino acids in thisregion have been shown
to be essential for
A-dependent
promoteractivation . However, deletion of
-helix
E also impaired theability of Spo0A to activate
H-directed
transcription . In orderto explore further the possibility that
-helix
E may be essentialfor stimulating
H-directed
transcription, we sought to identifyintragenic suppressors of the
deletions . A selection for sporulation-proficientderivatives of the
-helix
E deletion strains failed, probablybecause sporulation would require
restoration of both
A-directed
and
H-directed
transcription . However, during this procedurewe discovered that a
single valine [GTT]-to-alanine [GCT] substitutionat position 8 [V8A]
in the deletion 1 derivative of Spo0A suppressedthe effect of the
deletion on
H-dependent
spoIIA-lacZ expression[Fig . 4] . The V8A
substitution did not suppress the effect ofthe deletion on
spoIIG-lacZ [Fig . 4] expression, nor did it
restore formation of heat-resistant spores [data not shown].
Therefore,
-helix
E in the V8A-substituted Spo0A is not requiredfor activation of the
H-dependent
spoIIA promoter, while
-helix
E is required for activation of the
A-dependent
spoIIG promoter.
|
Since
-helix
E is not required for stimulation of
H-directed
transcription, at least not by the V8A-substituted Spo0A, how
does the deletion of
-helix
E affect
H-directed
transcriptionand how does the V8A substitution suppress the effect
of thedeletion on
H-directed
transcription? Immunoblot analyses ofSpo0A accumulation during
sporulation revealed that the deletionderivatives of Spo0A
accumulated to levels that were at leasttwo- to fourfold lower than
that of wild-type Spo0A [data notshown] . These lower levels of
accumulation may have been causedby small decreases in stability of
the deletion derivativesof Spo0A and may have been compounded by the
requirement ofSpo0A for stimulating transcription of its own
structural gene[14] . However, the small decrease
in accumulation of the Spo0Adeletion derivatives probably played no
role in the reductionof Spo0A-dependent promoter activation .
Immunoblot analysesshowed that the V8A substitution did not
substantially increasethe accumulation of Spo0A [data not shown] .
Nevertheless, theV8A substitution restored activation of the
spoIIA promoterby the deletion 1 derivative Spo0A . One possible
explanationfor these results is that the V8A substitution increases
thefraction of the Spo0A that is phosphorylated, which allows the
protein to stimulate transcription more efficiently . Consistent
with this hypothesis is the observation by Stephenson et al.[13]
that N12 of Spo0A is critical for interaction with theSpo0E
phosphatase . Two highly conserved aspartate residues,D10 and D11,
that form part of the acid pocket at the phosphorylationsite are
located between N12 and V8 [6] . Therefore, it is possible
that the V8A substitution may reduce interaction with the Spo0E
phosphatase, resulting in higher levels of Spo0A phosphorylation.The
equivalent residue of Spo0A V8 is normally a hydrophobicresidue in
response regulator receiver domains and lies in thefirst element of
the secondary structure, a ß-strandthat contributes to the
positioning of the ß1-
1
loopcontaining the residue D10-N12, and so this is our preferred
explanation.
Other possible mechanisms by which the V8A substitution restores
activation of
H-directed
transcription by the
-helix
E deletionderivative of Spo0A would include creation of an
interactionbetween the N-terminal domain of Spo0A and RNA polymerase
thatcompensates for an interaction with RNA polymerase that was
lost upon deletion of
-helix
E or a model in which the V8A affectsinteraction between the N- and
C-terminal domains of Spo0A.We cannot eliminate the former model,
but it seems unlikelythat substitution of valine for alanine, which
effectively removesside chain volume, would establish a new
interaction betweenproteins and seems likelier that the alanine
substitution wouldeliminate an interaction, such as between Spo0A
and Spo0E . Wealso cannot completely eliminate the latter model .
However,if the V8A substitution affects the interaction between the
C- and N-terminal domains of Spo0A, the effect on the conformation
of the C-terminal domain would likely be very small . This effect
would not likely be great enough to compensate for the absence
of
-helix
E if this helix plays a direct role in stimulating
H-RNA
polymerase . Therefore, we conclude that
-helix
E in Spo0Aprobably is not directly involved in interaction with
H-RNA
polymerase . If
-helix
E does not interact with
H-RNA
polymerase,then another region of Spo0A probably interacts with
H-RNA
polymerase.Presently the best candidate for a region of Spo0A that
interactswith
H-RNA
polymerase is at the extreme C terminus, where aminoacid
substitutions at positions 257, 258, and 260 have beenshown by
Rowe-Magnus et al . [9] and Perego et al . [8]
to reduceactivation of the
H-dependent
promoter spoIIA . However, as Rowe-Magnuset al . [9]
discuss in their paper, they could not eliminatean indirect role for
this region in activation of
H-dependent
promoters.
| ACKNOWLEDGMENTS |
|---|
This work was supported by Public Health Service grant GM54395from
the National Institute of General Medical Sciences.
| FOOTNOTES |
|---|
* Corresponding author . Mailing address: Department of
Microbiology & Immunology, Emory University School of Medicine, Atlanta, GA
30322 . Phone: [404] 727-5969 . Fax: [404] 727-3659 . E-mail: moran@microbio.emory.edu.
| REFERENCES |
|---|
What Is Environmental Microbiology?,
What Is Amino Acid?,
What Is Molecular Biology?,
What Is Growth Medium?,
What Is Salmonella?,
s,
Microbes,
i,
Bacteriology,
o,
Microbe,
a,
Microorganism,
i,
Microorganisms,
a,
Botulin,
e,
Multidrug resistant,
i,
Cryptococci,
r,
Escherichia coli,
o,
Clostridia,
a,
Escherichia coli,
e,
Bacteriophages,
o,
Saccharomyces yeast,
e,
Streptococcal,
c,
Microbial,
s,
Halophilic bacterium,
s,
Salmonella,
o,
Acinetobacter,
o,
Cryptococci,
n,
Escherichia coli,
c,
Cellulomanas,
r,
Micrococci,
i,
Yeasts,
a,
Pasteurella,
e,
Bacteroides,
n,
Pseudomonas aeruginosa
© 2005
Transgalactic Ltd (manufacturer of Bioscreen C software) |
Privacy Statement | P.O. Box
1393, 00101 Helsinki, Finland,
Last modified: May 25, 2005
| ||||||